Clinical Trial Update: To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating strategies to prevent bone loss in women with systemic lupus erythematosus who are treated with glucocorticoids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Genelabs Technologies | Conditions: Lupus | Phase 3 | Status: UNKNOWN